ESC Premium Access

Genesis of epicardial adipocytes and its association with progenitor markers, muscarinic receptor type 3 and b-blockers intake in patients with cardiovascular disease

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Presentation

About the speaker

Ms Xiaoran Fu

Instituto de Investigacion Sanitaria de Santiago, Santiago de Compostela (Spain)
0 follower

202 more presentations in this session

Monounsaturated fatty acid antagonizes saturated fatty acid-induced cardiomyopathy via improving membrane fatty acid composition and endoplasmic reticulum stress

Speaker: Doctor T. Yamamoto (Tokyo, JP)

Thumbnail

MicroRNA let-7a, -7e and -133a attenuate hypoxia-induced atrial fibrosis via targeting collagen expression and the JNK pathway in HL1 cardiomyocytes

Speaker: Doctor C. Lo (Taichung, TW)

Thumbnail

Acute administration of the olive constituent, oleuropein, combined with post-conditioning mechanism exerts cardioprotective effects by modulating oxidative defense

Speaker: Professor I. Andreadou (Athens, GR)

Thumbnail

Coronary artery cavitation as a trigger for atherosclerotic plaque progression: a numerical and computational fluid dynamic demonstration

Speaker: Associate Professor G. Rigatelli (Rovigo, IT)

Thumbnail

Melatonin receptor blockade slows ventricular conduction by IK1 downregulation

Speaker: Doctor M. Gonotkov (Syktyvkar, RU)

Thumbnail

Access the full session

Basic science e-posters

Speakers: Ms X. Fu, Doctor T. Yamamoto, Doctor C. Lo, Professor I. Andreadou, Associate Professor G. Rigatelli...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

What's next to reduce cardiovascular risk? - Chat Moderator.

27 August 2021

ESC Premium Access

Reduced tissue sodium content is related to improvement of vascular function in patients with chronic heart failure treated with the SGLT2 inhibitor empagliflozin

27 August 2021

ESC Premium Access

Hemoglobin, anemia, and clinical outcomes in vericiguat global study in subjects with heart failure with reduced ejection fraction (VICTORIA)

27 August 2021

This platform is supported by

logo Novo Nordisk